Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658123 · ClinicalTrials.gov registry record · NA
Reducing Readmissions in High-Risk Ostomates
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT02658123: Clinical Trial NA study, sponsored by Washington University School of Medicine.
NCT02658123 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02658123, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
Preventing complications and readmission after ostomy surgery will decrease the cost of healthcare, improve patient safety, reduce the cost of durable medical equipment required by ostomates, ensure continued specialized care is available, and potentially improve both short and long-term quality of life (QOL) for patients by reducing morbidity and mortality associated with ostomy surgery. The purpose of this study is to measure the effectiveness of patient centered interventions/care pathways and to determine the impact on healthcare utilization, 30-day hospital readmissions, and QOL.
Interventions
- OTHER Pre-operative education (standard of care)
- OTHER Home health care visits (standard of care)
- OTHER Follow-up post-operative visits
- OTHER Patient Data Collection Form
- OTHER Healthcare Utilization Form
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-08-22 |
| Phase | NA |
Why NCT02658123 stopped before completion
NCT02658123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Pre-operative education (standard of care) is the first listed.
NCT02658123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02658123 about?
NCT02658123 is a clinical study titled "Reducing Readmissions in High-Risk Ostomates". Preventing complications and readmission after ostomy surgery will decrease the cost of healthcare, improve patient safety, reduce the cost of durable medical equipment required by ostomates, ensure continued specialized care is available, and potentially improve both short and long-term quality of ...
What is the current status of trial NCT02658123?
This trial is currently terminated. It is a NA study. The enrollment target is 94 participants. The study started on 2016-04. Estimated completion is 2018-08-22.
What interventions are being tested in trial NCT02658123?
The interventions under investigation include: Pre-operative education (standard of care) (OTHER), Home health care visits (standard of care) (OTHER), Follow-up post-operative visits (OTHER), Patient Data Collection Form (OTHER), Healthcare Utilization Form (OTHER).
Who is sponsoring clinical trial NCT02658123?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02658123's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia